Tender

QUB/2163/21 - Supply, delivery, installation, commissioning, maintenance, consumables for Lot 1: Hydrogenation Reaction; Lot 2: Flow Reactor; Lot 3: Photocube Reactor

  • Queen's University Belfast

F02: Contract notice

Notice identifier: 2021/S 000-028209

Procurement identifier (OCID): ocds-h6vhtk-02f59e

Published 11 November 2021, 10:09am



Section one: Contracting authority

one.1) Name and addresses

Queen's University Belfast

University Road

Belfast

BT7 1NN

Contact

Dónall Patton

Email

d.patton@qub.ac.uk

Country

United Kingdom

NUTS code

UKN06 - Belfast

Internet address(es)

Main address

https://www.qub.ac.uk/

Buyer's address

https://www.qub.ac.uk/directorates/FinanceDirectorate/

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://in-tendhost.co.uk/queensuniversitybelfast

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://in-tendhost.co.uk/queensuniversitybelfast

Tenders or requests to participate must be submitted to the above-mentioned address

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Education


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

QUB/2163/21 - Supply, delivery, installation, commissioning, maintenance, consumables for Lot 1: Hydrogenation Reaction; Lot 2: Flow Reactor; Lot 3: Photocube Reactor

Reference number

QUB/2163/21

two.1.2) Main CPV code

  • 38000000 - Laboratory, optical and precision equipments (excl. glasses)

two.1.3) Type of contract

Supplies

two.1.4) Short description

The Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT) is an industry-focused partnership of Life and Health Science (LHS) companies and Academia, aligned to NI Health and Economy strategies. By addressing critical commercial gaps, the Consortium's aim is to transform the productivity of each Commercial Partner and the broader LHS sector in NI. NIPBT will deploy the grant funding to collaboratively develop R and D capabilities that industry partners require. Queen’s is leading the NIPBT and as such is tasked with procuring and installing the following Systems within the Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, 97 Lisburn Road, Belfast, BT9 7 AE:• Lot 1: Hydrogenation Reaction System• Lot 2: Flow Reactor System• Lot 3: Photocube Reactor SystemEconomic Operators must tender for All Lots – Lot 1, Lot 2 and Lot 3. Queen’s reserves the right to award contracts for any, all, or no Lots under this ITT.

two.1.6) Information about lots

This contract is divided into lots: Yes

Tenders may be submitted for all lots

two.2) Description

two.2.1) Title

Contract for the supply, delivery, installation, commissioning, maintenance, training and purchase of consumables for a Hydrogenation Reaction System

Lot No

1

two.2.2) Additional CPV code(s)

  • 38000000 - Laboratory, optical and precision equipments (excl. glasses)

two.2.3) Place of performance

NUTS codes
  • UKN06 - Belfast
Main site or place of performance

Belfast, Northern Ireland

two.2.4) Description of the procurement

The Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT) is an industry-focused partnership of Life and Health Science (LHS) companies and Academia, aligned to NI Health and Economy strategies. By addressing critical commercial gaps, the Consortium's aim is to transform the productivity of each Commercial Partner and the broader LHS sector in NI. NIPBT will deploy the grant funding to collaboratively develop R&D capabilities that industry partners require. Queen’s is leading the NIPBT and as such is tasked with procuring and installing the following System within the Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, 97 Lisburn Road, Belfast, BT9 7 AE:Lot 1: Hydrogenation Reaction SystemEconomic Operators must tender for All Lots – Lot 1, Lot 2 and Lot 3. Where an Economic Operator fails to bid for all Lots their bid will be rejected.Lots will be evaluated independently and Queen’s reserves the right to award contracts for any, all, or no Lots under this ITT. This decision will be solely at the discretion of Queen’s. Funding DeadlinePlease note: it may be a requirement of the funding body associated with this procurement that delivery and invoicing take place by 31 March 2022. Where this is the case, the 1st ranked supplier will be asked to confirm their ability to meet the required deadline prior to the award of the contract being confirmed.Where the 1st ranked bidder is unable to meet the deadline, their bid will be rejected and the 2nd ranked bidder will be asked to confirm their ability to meet the deadline and so on until an Economic Operator can confirm the date can be met. Time is of the essence when it comes to delivery of equipment within stipulated deadlines.

two.2.5) Award criteria

Quality criterion - Name: Technical / Weighting: 50%

Cost criterion - Name: Price / Weighting: 50%

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

60

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

One-off purchases with options to purchase maintenance and associated consumables for up to either 5 years or the end of useful life of the equipment

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: Yes

Identification of the project

The Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT)

two.2) Description

two.2.1) Title

Contract for the supply, delivery, installation, commissioning, maintenance, training and purchase of consumables for a Flow Reactor System

Lot No

2

two.2.2) Additional CPV code(s)

  • 38000000 - Laboratory, optical and precision equipments (excl. glasses)

two.2.3) Place of performance

NUTS codes
  • UKN06 - Belfast
Main site or place of performance

Belfast, Northern Ireland

two.2.4) Description of the procurement

The Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT) is an industry-focused partnership of Life and Health Science (LHS) companies and Academia, aligned to NI Health and Economy strategies. By addressing critical commercial gaps, the Consortium's aim is to transform the productivity of each Commercial Partner and the broader LHS sector in NI. NIPBT will deploy the grant funding to collaboratively develop R&D capabilities that industry partners require. Queen’s is leading the NIPBT and as such is tasked with procuring and installing the following System within the Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, 97 Lisburn Road, Belfast, BT9 7 AE:Lot 2: Flow Reactor SystemEconomic Operators must tender for All Lots – Lot 1, Lot 2 and Lot 3. Where an Economic Operator fails to bid for all Lots their bid will be rejected.Lots will be evaluated independently and Queen’s reserves the right to award contracts for any, all, or no Lots under this ITT. This decision will be solely at the discretion of Queen’s. Funding DeadlinePlease note: it may be a requirement of the funding body associated with this procurement that delivery and invoicing take place by 31 March 2022. Where this is the case, the 1st ranked supplier will be asked to confirm their ability to meet the required deadline prior to the award of the contract being confirmed.Where the 1st ranked bidder is unable to meet the deadline, their bid will be rejected and the 2nd ranked bidder will be asked to confirm their ability to meet the deadline and so on until an Economic Operator can confirm the date can be met. Time is of the essence when it comes to delivery of equipment within stipulated deadlines.

two.2.5) Award criteria

Quality criterion - Name: Technical / Weighting: 50%

Cost criterion - Name: Price / Weighting: 50%

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

60

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

One-off purchases with options to purchase maintenance and associated consumables for up to either 5 years or the end of useful life of the equipment

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: Yes

Identification of the project

The Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT)

two.2) Description

two.2.1) Title

Contract for the supply, delivery, installation, commissioning, maintenance, training and purchase of consumables for a Photocube Reactor System

Lot No

3

two.2.2) Additional CPV code(s)

  • 38000000 - Laboratory, optical and precision equipments (excl. glasses)

two.2.3) Place of performance

NUTS codes
  • UKN06 - Belfast
Main site or place of performance

Belfast, Northern Ireland

two.2.4) Description of the procurement

The Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT) is an industry-focused partnership of Life and Health Science (LHS) companies and Academia, aligned to NI Health and Economy strategies. By addressing critical commercial gaps, the Consortium's aim is to transform the productivity of each Commercial Partner and the broader LHS sector in NI. NIPBT will deploy the grant funding to collaboratively develop R&D capabilities that industry partners require. Queen’s is leading the NIPBT and as such is tasked with procuring and installing the following System within the Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, 97 Lisburn Road, Belfast, BT9 7 AE:Lot 3: Photocube Reactor SystemEconomic Operators must tender for All Lots – Lot 1, Lot 2 and Lot 3. Where an Economic Operator fails to bid for all Lots their bid will be rejected.Lots will be evaluated independently and Queen’s reserves the right to award contracts for any, all, or no Lots under this ITT. This decision will be solely at the discretion of Queen’s. Funding DeadlinePlease note: it may be a requirement of the funding body associated with this procurement that delivery and invoicing take place by 31 March 2022. Where this is the case, the 1st ranked supplier will be asked to confirm their ability to meet the required deadline prior to the award of the contract being confirmed.Where the 1st ranked bidder is unable to meet the deadline, their bid will be rejected and the 2nd ranked bidder will be asked to confirm their ability to meet the deadline and so on until an Economic Operator can confirm the date can be met. Time is of the essence when it comes to delivery of equipment within stipulated deadlines.

two.2.5) Award criteria

Quality criterion - Name: Technical / Weighting: 30%

Cost criterion - Name: Price / Weighting: 70%

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

60

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

One-off purchases with options to purchase maintenance and associated consumables for up to either 5 years or the end of useful life of the equipment

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: Yes

Identification of the project

The Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT)


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

Accelerated procedure

Justification:

Queen's will be availing of Article 27 (3), Public Contracts Regulations 2015; where a state of urgency duly substantiated by the contracting authority renders impracticable the time limit laid down in the second subparagraph of paragraph 1, it may fix a time limit which shall be not less than 15 days from the date on which the contract notice was sent.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Date

29 November 2021

Local time

4:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.6) Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until: 11 March 2022

four.2.7) Conditions for opening of tenders

Date

29 November 2021

Local time

4:01pm


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.2) Information about electronic workflows

Electronic ordering will be used

Electronic invoicing will be accepted

Electronic payment will be used

six.4) Procedures for review

six.4.1) Review body

Queen's University Belfast

University Road

Belfast

BT7 1NN

Email

procurement@qub.ac.uk

Country

United Kingdom

Internet address

https://www.qub.ac.uk/directorates/FinanceDirectorate/

six.4.3) Review procedure

Precise information on deadline(s) for review procedures

This authority will incorporate a standstill period at the point information on the award of the contract is communicated to Tenderers. That notification will provide full information on the award decision. The standstill period, which will be for a minimum of 10 calendar days, provides time for unsuccessful tenderers to challenge the award decision before the contract is entered into.The Public Contract Regulations 2015 (SI 2015/102) provide for aggrieved parties who have been harmed or are at risk of harm by a breach of the rules to take action in the High Court (England, Wales and Northern Ireland).